ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Methenamine for Prevention of Recurrent Urinary Tract Infections in Adult Solid Organ Transplant Recipients

H. Sweiss1, S. Bhayana2, R. Hall1, J. Nelson1, E. Kincaide1

1University Health System, The University of Texas at Austin, College of Pharmacy, Pharmacotherapy Division, Austin, TX, The University of Texas Health Science Center at San Antonio, San Antonio, TX, 2University Health System, The University of Texas Health Science Center at San Antonio, San Antonio, TX

Meeting: 2020 American Transplant Congress

Abstract number: A-197

Keywords: Infection, Kidney transplantation, Kidney/liver transplantation, Recurrence

Session Information

Session Name: Poster Session A: Kidney Infectious Excluding Polyoma & Viral Hepatitis

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Evaluate efficacy of methenamine for prevention of recurrent urinary tract infections (rUTI) in transplant recipients.

*Methods: This retrospective review included patients greater than or equal to 18 years of age who received an abdominal transplant at University Transplant Center with rUTI from 1/2009 to 9/2019. rUTI were defined as greater than or equal to 2 UTI within 6 months or 3 UTI within a year documented by cultures with greater than 10,000 Colony Forming Units. Patients who met rUTI diagnostic criteria were divided into the following groups: (1) Methenamine: received methenamine for greater than or equal to 90 days or (2) No Prophylaxis: did not receive rUTI prophylaxis. Patients on concomitant bacterial suppression therapy for rUTI were excluded. Rate of rUTI, treatment failure, bacteremia, hospitalization, and isolation of multi-drug resistant organism (MDRO) were assessed per 90 patient-days follow-up. A matched pair analysis compared 90-days pre-methenamine therapy initiation (MTI) to post-MTI. Results were reported per 90 patient-days follow-up. Median of average duration of antibiotic days was collected in all groups.

*Results: A total of 62 patients were included. Time from rUTI diagnosis to MTI was 480 days (IQR 188-1508). Endpoints were significantly reduced in the methenamine group compared to no prophylaxis (Table 1). Matched pair analysis (pre-MTI vs post MTI) revealed a decrease in rUTI, hospitalization, and antibiotic days in post-MIT group (Table 2).

 border=

 border=

*Conclusions: To our knowledge, this is the first study evaluating the efficacy of methenamine to patients receiving no prophylaxis for rUTI in abdominal transplant recipients. This study supports MTI for rUTI in abdominal transplant recipients to reduce rate of rUTI, treatment failure, bacteremia, hospitalization, and MDRO isolated. Significant reduction in rUTI was also evident when evaluating cohorts pre- and post-MTI.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Sweiss H, Bhayana S, Hall R, Nelson J, Kincaide E. Methenamine for Prevention of Recurrent Urinary Tract Infections in Adult Solid Organ Transplant Recipients [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/methenamine-for-prevention-of-recurrent-urinary-tract-infections-in-adult-solid-organ-transplant-recipients/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences